losartan and apraclonidine

losartan has been researched along with apraclonidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Agnati, LF; Fior, DR; Fuxe, K; Hedlund, PB; Narváez, JA; Yang, SN	1

Other Studies

2 other study(ies) available for losartan and apraclonidine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Evidence for an antagonistic angiotensin II/alpha 2-adrenoceptor interaction in the nucleus tractus solitarii. European journal of pharmacology, 1994, Sep-12, Volume: 262, Issue:3 Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding, Competitive; Biphenyl Compounds; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Imidazoles; Losartan; Male; Microinjections; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Angiotensin; Software; Solitary Nucleus; Specific Pathogen-Free Organisms; Tetrazoles	1994

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Evidence for an antagonistic angiotensin II/alpha 2-adrenoceptor interaction in the nucleus tractus solitarii.

European journal of pharmacology, 1994, Sep-12, Volume: 262, Issue:3

Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding, Competitive; Biphenyl Compounds; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Imidazoles; Losartan; Male; Microinjections; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Angiotensin; Software; Solitary Nucleus; Specific Pathogen-Free Organisms; Tetrazoles

1994